BayMed Venture Partners
Venture capitalSan Francisco · Pre-Seed–Series B · 2 people tracked
Investment thesis
BayMed Venture Partners invests in maturing early-stage medical device and digital health companies that address important unmet clinical needs across North America and Israel. The firm seeks disruptive, differentiated innovation on a global scale and applies deep clinical and cross-functional operational expertise to support portfolio company success. Leveraging extensive relationships for global sourcing and deal flow, it targets the most compelling early-stage opportunities. Its results-driven, exit-focused methodology positions the firm as a hands-on partner, offering guidance intended to drive exceptional growth and deliver value for portfolio companies, investment partners, and the broader healthcare system.
Source: firm website, verified Aug 7, 2026.
Team · 2 people
from public directoriesWhat they invest in
from 5 of 12 portfolio companiesHealthtech ×4Medical Devices ×4Biotech ×2AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Enterprise Software ×1
HQs:United States×2
Investments · 12 tracked
founders shown can be your intro pathAppend Medical develops a transcatheter system using vacuum-based technology to treat non-valvular atrial fibrillation by occluding the left atrial appendage without implanting a device in the heart.
Deep TechHealthtechMedical Devices
Leonid Sternik(MD, Inventor and cardiac surgeon)
Cardiosense develops the CardioTag, a noninvasive point-of-care cardiac monitoring device that measures pulmonary capillary wedge pressure to enable early detection and management of worsening heart failure across emergency, inpatient, and outpatient settings.
AI & Machine LearningDigital HealthMedical DevicesChicago, US
Jeff Terrell(Director)Omer Tolga Inan(Director)Amit K. Gupta(Executive Officer, Director)Andrew Michael Carek(Executive Officer)Daniel Gottlieb(Director)
First Light Diagnostics develops the MultiPath benchtop analyzer, an instrument for rapid diagnostic testing.
BiotechHealthtechMedical Devices
Thermo Fisher Scientific operates a commercial platform for registered customers, distributors, and authorized representatives to purchase products and services in the life sciences sector.
BiotechEnterprise SoftwareHealthtech
Frequently asked questions
- What stage does BayMed Venture Partners invest at?
- BayMed Venture Partners invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does BayMed Venture Partners focus on?
- BayMed Venture Partners focuses on Digital Health, Healthtech, Medical Devices.
- Where is BayMed Venture Partners located?
- BayMed Venture Partners is headquartered in San Francisco, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Lang Sheng Investment (朗盛投资) is a leading Chinese investment firm focused on the large healthcare sector, with experience in screening, investing in, and supporting medical and health companies.